154 related articles for article (PubMed ID: 31317367)
1. Cytoplasmic SIRT1 inhibits cell migration and invasion by impeding epithelial-mesenchymal transition in ovarian carcinoma.
Yang T; Zhou R; Yu S; Yu S; Cui Z; Hu P; Liu J; Qiao Q; Zhang J
Mol Cell Biochem; 2019 Sep; 459(1-2):157-169. PubMed ID: 31317367
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic SIRT1 promotes paclitaxel resistance in ovarian carcinoma through increased formation and survival of polyploid giant cancer cells.
Xu H; Zeng S; Wang Y; Yang T; Wang M; Li X; He Y; Peng X; Li X; Qiao Q; Zhang J
J Pathol; 2023 Oct; 261(2):210-226. PubMed ID: 37565313
[TBL] [Abstract][Full Text] [Related]
3. SIRT1 deacetylates KLF4 to activate Claudin-5 transcription in ovarian cancer cells.
Zhang X; Chen J; Sun L; Xu Y
J Cell Biochem; 2018 Feb; 119(2):2418-2426. PubMed ID: 28888043
[TBL] [Abstract][Full Text] [Related]
4. Functional role of SIRT1-induced HMGB1 expression and acetylation in migration, invasion and angiogenesis of ovarian cancer.
Jiang W; Jiang P; Yang R; Liu DF
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4431-4439. PubMed ID: 30058682
[TBL] [Abstract][Full Text] [Related]
5. Rikkunshito attenuates induction of epithelial-mesenchymal switch via activation of Sirtuin1 in ovarian cancer cells.
Kanda R; Miyagawa Y; Wada-Hiraike O; Hiraike H; Fukui S; Nagasaka K; Ryo E; Fujii T; Osuga Y; Ayabe T
Endocr J; 2020 Apr; 67(4):379-386. PubMed ID: 31839623
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic Acid Promotes Epithelial to Mesenchymal Transition in Ovarian Cancer Cells by Repressing SIRT1.
Ray U; Roy SS; Chowdhury SR
Cell Physiol Biochem; 2017; 41(2):795-805. PubMed ID: 28214851
[TBL] [Abstract][Full Text] [Related]
7. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 expression regulates the transformation of resistant esophageal cancer cells via the epithelial-mesenchymal transition.
Qin T; Liu W; Huo J; Li L; Zhang X; Shi X; Zhou J; Wang C
Biomed Pharmacother; 2018 Jul; 103():308-316. PubMed ID: 29656187
[TBL] [Abstract][Full Text] [Related]
9. PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells.
Sun L; Li H; Chen J; Iwasaki Y; Kubota T; Matsuoka M; Shen A; Chen Q; Xu Y
J Cell Sci; 2013 Sep; 126(Pt 17):3939-47. PubMed ID: 23843607
[TBL] [Abstract][Full Text] [Related]
10. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.
Choupani J; Mansoori Derakhshan S; Bayat S; Alivand MR; Shekari Khaniani M
J Cell Physiol; 2018 Jun; 233(6):4443-4457. PubMed ID: 29194618
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma.
Hao C; Zhu PX; Yang X; Han ZP; Jiang JH; Zong C; Zhang XG; Liu WT; Zhao QD; Fan TT; Zhang L; Wei LX
BMC Cancer; 2014 Dec; 14():978. PubMed ID: 25522783
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.
Cha BK; Kim YS; Hwang KE; Cho KH; Oh SH; Kim BR; Jun HY; Yoon KH; Jeong ET; Kim HR
Oncotarget; 2016 Aug; 7(35):57213-57227. PubMed ID: 27528025
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
Ping H; Guo L; Xi J; Wang D
Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
[TBL] [Abstract][Full Text] [Related]
14. Effect of SIRT1 Gene on Epithelial-Mesenchymal Transition of Human Prostate Cancer PC-3 Cells.
Cui Y; Li J; Zheng F; Ouyang Y; Chen X; Zhang L; Chen Y; Wang L; Mu S; Zhang H
Med Sci Monit; 2016 Feb; 22():380-6. PubMed ID: 26847404
[TBL] [Abstract][Full Text] [Related]
15. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
[TBL] [Abstract][Full Text] [Related]
16. SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells.
Sun T; Jiao L; Wang Y; Yu Y; Ming L
Cell Death Dis; 2018 Jan; 9(2):136. PubMed ID: 29374154
[TBL] [Abstract][Full Text] [Related]
17. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
18. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Yu J; Han Q; Cui Y
Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
[TBL] [Abstract][Full Text] [Related]
19. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
[TBL] [Abstract][Full Text] [Related]
20. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
